multifunctional Alzheimer's disease modifying agents (University of Barcelona/Fundació BOSCH I GIMPERA)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug Namemultifunctional Alzheimer's disease modifying agents (University of Barcelona/Fundació BOSCH I GIMPERA)
Drug Alias NameAVCRI-104P4
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAcetylcholinesterase inhibitorsBeta amyloid A4 protein inhibitorsBeta amyloid A4 protein aggregation inhibitors +[4] 
TargetsBeta-secretase 1AcetylcholinesteraseBeta amyloid A4 protein
Therapy Area/IndicationsAlzheimer Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySpain
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesUniversitat De Barcelona
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesGenoma EspañaUniversitat De Barcelona
Active IndicationsN/A
Inactive IndicationsAlzheimer Disease

Other Information

ATC CodeN/A
Related LinksN/A